As of Oct 25
| +0.14 / +2.21%|
The 4 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 13.50, with a high estimate of 16.00 and a low estimate of 11.00. The median estimate represents a +108.33% increase from the last price of 6.48.
The current consensus among 5 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.